Anticancer Research

Visit the official website of the International Institute of Anticancer Research

Current Issue

October 2026 (Vol. 46 Issue 10) Table of Contents

Issue highlights

Triptolide as a Chemosensitizer in Human Papillomavirus Head and Neck Squamous Cell Carcinoma Through TP53
Long-Term Outcomes of Ewing Sarcoma of the Foot and Ankle
Baseline Gut Microbiota Composition Links Immune–nutritional Status to Clinical Outcomes in Non-small Cell Lung Cancer Treated With Atezolizumab-based Immunotherapy: A Multicenter Prospective Study
Vascular Proliferation Index Via a Single-Cell Analysis Is a Superior Prognostic Biomarker to Microvessel Density in Stage II/III Colorectal Cancer
Conventional One-surgeon Team (COST) Versus Two-attending Surgeons Approach (TASA) in Lymph Node Harvest in Patients Undergoing Pancreaticoduodenectomy for Cancer

Latest Articles

You have access
Baseline Gut Microbiota Composition Links Immune–nutritional Status to Clinical Outcomes in Non-small Cell Lung Cancer Treated With Atezolizumab-based Immunotherapy: A Multicenter Prospective Study
FUMIHIRO SHOJI, SHO WAKASU, KEISUKE KOSAI, FUMIHIKO KINOSHITA, TAICHI MATSUBARA, SHINKICHI TAKAMORI, YUKA KOZUMA, TAKATOSHI FUJISHITA, GOUJI TOYOKAWA, TETSUZO TAGAWA, YOSHIHIDE TANAKA, MASAFUMI YAMAGUCHI, TATSURO OKAMOTO, KOJI YAMAZAKI and YOSHIHIKO MAEHARA

Anticancer Research October 2026, 46 (10) 5565-5575; DOI: https://doi.org/10.21873/anticanres.18400
Open Access
Triptolide as a Chemosensitizer in Human Papillomavirus Head and Neck Squamous Cell Carcinoma Through TP53
WILLIAM KAMM, QI ZHANG, LINDSEY MORTENSEN, BEVERLY WUERTZ and FRANK G. ONDREY

Anticancer Research October 2026, 46 (10) 5359-5373; DOI: https://doi.org/10.21873/anticanres.18382
You have access
FXR1 Promotes Esophageal Squamous Cell Carcinoma via JAK2/STAT3/B7-H3 Pathway
XIAOLI WANG, QIANWEN MIAO, XIAOYUAN LIU, FEN LIU, YING ZHANG, CAILU SHEN, FANG WANG, DI SHEN and XIAOSONG GE

Anticancer Research October 2026, 46 (10) 5467-5481; DOI: https://doi.org/10.21873/anticanres.18391
You have access
Impact of Resection Margin Width on Local Control and Prognostic Factors in HER2-enriched and Triple-negative Breast Cancer in the Modern Systemic Treatment Era
WON ICK CHANG, BUM-SUP JANG, JI HYUN CHANG, KYUBO KIM and KYUNG HWAN SHIN

Anticancer Research October 2026, 46 (10) 5669-5678; DOI: https://doi.org/10.21873/anticanres.18410
Open Access
CLSPN Is Expressed in Pancreatic Cancer and Can Be a Target for Immunotherapy
HIDEHARU MIURA, KENJI MURATA, AIKO MURAI, YUKA MIZUE, KANTA HORI, SHOICHIRO TANGE, KENTA SASAKI, NAOKI SHIJUBOU, TERUFUMI KUBO, TOMOHIDE TSUKAHARA, KIYOTERU KASHIWAGI, TAKASHIGE ABE, MASASHI IDOGAWA, TAKAYUKI ANAZAWA, FUMITAKE HATA, TOSHIHIKO TORIGOE, RENA MORITA and YOSHIHIKO HIROHASHI

Anticancer Research October 2026, 46 (10) 5387-5397; DOI: https://doi.org/10.21873/anticanres.18384
Open Access
Long-Term Outcomes of Ewing Sarcoma of the Foot and Ankle
ANGELA M. MERCURIO, ALEXANDRA M. ARGUELLO, MIKAELA H. SULLIVAN, THANH P. HO, STEVEN I. ROBINSON, BRITTANY L. SIONTIS, KATIE N. LEE, MENG X. WELLIVER and MATTHEW T. HOUDEK

Anticancer Research October 2026, 46 (10) 5483-5488; DOI: https://doi.org/10.21873/anticanres.18392

Visit the official website of Anticancer Research.

Main menu

User menu

Search

Visit the official website of the International Institute of Anticancer Research

Current Issue

Issue highlights

Featured Articles

Latest Articles